Theragenics Expands Operations to Offer Contract Manufacturing Services for Radiopharmaceuticals
Leverages Robust Infrastructure and Expertise in Radioisotope Production
BUFORD, Ga., 16 September 2024 – Theragenics Corporation®, a recognized leader in minimally invasive brachytherapy and surgical solutions, announces the expansion of its services to include contract manufacturing for the radiopharmaceutical industry. This strategic move leverages Theragenics’ robust infrastructure and extensive experience in radioisotope production to support the growing demand for innovative diagnostic and therapeutic radiopharmaceuticals.
“Since 1981, Theragenics has been committed to providing advanced radiological technologies for cancer treatment,” said Mark Pugh, CEO of Theragenics Corporation. “By offering contract manufacturing services, we can extend this mission by supporting the delivery of next-generation radiopharmaceuticals.”
Proven Capabilities and Expertise
- High-Volume Radioisotope Production: Theragenics’ 134,000 square foot production facility houses 14 high-capacity cyclotrons, enabling efficient and reliable radioisotope production at commercial scale.
- Streamlined Operations: Theragenics’ vertically integrated approach encompasses manufacturing, processing, and shipping under one roof, offering shorter lead times, cost-effectiveness, and consistent quality.
- Strategic Location and Logistics Network: Situated near Atlanta with access to a major airport, Theragenics offers dedicated logistics personnel to manage domestic and international radiopharmaceutical shipments.
- Regulatory Compliance and Quality Assurance: Theragenics is committed to adhering to strict regulatory standards and maintaining the highest quality standards in its manufacturing processes.
“For decades, Theragenics has been at the forefront of radioisotope production,” said Amy Briscoe, Vice President of Operations and General Manager, Radioisotopes. “We are thrilled to now leverage our world-class facility and established expertise to provide contract manufacturing services to radiopharmaceutical companies seeking a reliable partner.”
About Theragenics
Theragenics (www.theragenics.com) is a leader in cutting-edge medical solutions, offering minimally invasive medical devices and radiation-based treatments that improve patient outcomes. Through our subsidiaries Arrotek (www.arrotek.com) and Galt Medical (www.galtmedical.com), we design and deliver a broad range of vascular access devices, needles, catheters, guidewires, and more. We also partner with global medical device companies to provide comprehensive design, manufacturing, and regulatory support services.
Contacts:
Tamera Barry
Sr. Group Marketing Manager
770-831-5137
radioisotopes@theragenics.com